This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The authors retrospectively formed surgical and medically managed cohorts of octogenarians with significant multivessel CAD. More than 600 medical records of patients older than 80 years who underwent angiography in the authors' institution were reviewed to identify 48 patients who were considered reasonable surgical candidates but had not undergone surgery. Patients were excluded if:
(1) their pathology was not primarily CAD;
(2) they had single-vessel or diffuse, nonsignificant multivessel disease;
(3) they were treated by transluminal angioplasty;
(4) they had severe comorbidities that would preclude CABG surgery; or (5) cardiac surgical consults found them not to be suitable surgical candidates. There were no significant differences in age, sex, left ventricular ejection fraction percentage or incidence of diabetes between the two groups. The surgical group had a significantly higher reported incidence of hypertension, (p=0.04). The average duration of follow-up was 38 months for the surgical cohort and 31 months for the medically managed cohort. This cohort was compared with 176 patients who underwent surgery, identified through the hospital database maintained for the New York State Cardiac Surgery Reporting Systems.
Study design
This was a retrospective cohort study.
Analysis of effectiveness
The main health outcomes considered were survival rates and quality of life. Quality of life (QoL) was assessed using the EuroQol questionnaire. EuroQol assesses mobility, self-care, usual activity, pain, and anxiety/depression. A utility or index score of 1 indicates full health. The seventh item of the EuroQol questionnaire regarding patients' overall impression of their present health was omitted because of difficulty in administering the question in telephone interviews.
Effectiveness results
The three-year survival rate was 80% for the surgical cohort and 64% for the medically managed cohort. For the subgroup of patients managed medically with a documented refusal of CABG surgery, a 50% ten-month survival rate was noted. In general, patients in the surgical cohort reported a better QoL across all five dimensions and perception of their general health in comparison with other people they knew. Patients in the surgical cohort were found to have an average utility or index score of 0.84, and patients in the medical cohort had an average score of 0.61, (p<0.001).
Patients in the group of the medical cohort who refused CABG surgery had a utility of 0.74.
Clinical conclusions
CABG surgery should be offered to octogenarians with multivessel CAD who are considered reasonable surgical candidates.
Measure of benefits used in the economic analysis
Quality-adjusted life years (QALYs) gained were calculated.
Direct costs
The authors calculated the total average direct costs associated with either CABG surgery or medical management by applying proxies of resource costs or RCCs (ratio of costs to charges) to actual resource utilisation. Six major resource categories were considered: in-patient room charge or emergency room use, operation or catheterisation suite use, diagnostics, therapeutics, rehabilitation (cardiac and respiratory) and professional payments. DRG and Medicare reimbursement schedules were also used. A 3% annual discount rate was applied.
Statistical analysis of costs
Costs were not analysed statistically, although statistical analysis was used extensively for other comparisons between groups.
